rs371086981
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM3PP1_ModeratePVS1PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The c.2T>G (p.Met1Arg) variant in GJB2 may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein. There have been multiple pathogenic variants observed in the region between this site and the next expected start codon (PVS1; ClinVar Variation IDs: 21387, 188758). There are also multiple pathogenic/likely pathogenic start-loss variants at this position which may indicate that this residue is critical to the function of the protein (ClinVar Variation IDs: 44729, 550716, 2070085, 371781). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The variant has been reported in an individual with prelingual and profound hearing loss in a compound heterozygous manner with the pathogenic variant c.35delG, p.G12Vfs (1 PM3 point, Clinvar ID: 17004) and segregated in two affected siblings (PP1_Moderate, PMID:36472766). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hearing loss based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel: PVS1, PM2_Supporting, PM3, PP1_Moderate (VCEP specifications version 2; 10.24.2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA387462304/MONDO:0019497/005
Frequency
Consequence
NM_004004.6 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB2 | NM_004004.6 | c.2T>G | p.Met1? | start_lost | 2/2 | ENST00000382848.5 | NP_003995.2 | |
GJB2 | XM_011535049.3 | c.2T>G | p.Met1? | start_lost | 2/2 | XP_011533351.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB2 | ENST00000382848.5 | c.2T>G | p.Met1? | start_lost | 2/2 | 1 | NM_004004.6 | ENSP00000372299.4 | ||
GJB2 | ENST00000382844.2 | c.2T>G | p.Met1? | start_lost | 1/1 | 6 | ENSP00000372295.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 1A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 12, 2017 | - - |
Nonsyndromic genetic hearing loss Pathogenic:1
Pathogenic, reviewed by expert panel | curation | ClinGen Hearing Loss Variant Curation Expert Panel | Mar 28, 2024 | The c.2T>G (p.Met1Arg) variant in GJB2 may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein. There have been multiple pathogenic variants observed in the region between this site and the next expected start codon (PVS1; ClinVar Variation IDs: 21387, 188758). There are also multiple pathogenic/likely pathogenic start-loss variants at this position which may indicate that this residue is critical to the function of the protein (ClinVar Variation IDs: 44729, 550716, 2070085, 371781). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The variant has been reported in an individual with prelingual and profound hearing loss in a compound heterozygous manner with the pathogenic variant c.35delG, p.G12Vfs (1 PM3 point, Clinvar ID: 17004) and segregated in two affected siblings (PP1_Moderate, PMID: 36472766). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hearing loss based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel: PVS1, PM2_Supporting, PM3, PP1_Moderate (VCEP specifications version 2; 10.24.2023). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2023 | For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of the initiator codon alters GJB2 gene expression (PMID: 12189493). ClinVar contains an entry for this variant (Variation ID: 551915). Disruption of the initiator codon has been observed in individuals with autosomal recessive non-syndromic deafness (PMID: 9482292, 10218527, 18941476, 20146813, 29605365). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the GJB2 mRNA. The next in-frame methionine is located at codon 34. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at